Immunovant

long distance runners race ultramarathon marathon
Biotech

Immunovant promotes next-gen FcRn drug in race to rival Vyvgart

Immunovant’s decision to prioritize a next-gen FcRn antibody over phase 3 myasthenia gravis prospect batoclimab means Vyvgart’s crown remains secure.
James Waldron May 30, 2024 7:02am
light idea burst ruin destroy lightning shot

JPM24: Roivant CEO has ‘pangs of regret’ for letting Telavant go

Jan 12, 2024 10:30am
An arrow incrementally going up stairs before pointing straight up Blue background

Immunovant posts midphase FcRn data in Graves’, plots next steps

Dec 21, 2023 7:00am
graphic image of a cube with an arrow nailing the bullseye

Roivant FcRn inhibitor avoids cholesterol problem, shares spike

Sep 26, 2023 10:56am
china chinese Asia

Harbour ships phase 3 data to take lead in autoimmune race

Mar 6, 2023 6:50am
photo of a pair of binoculars perched on a rock aimed at the rising sun

Matt Gline wants you to stop seeing Roivant as a discard company

Jan 25, 2023 10:45am